Article
Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers.
Thorax - 1 Aug 2003
Joos L, Weir T D, Connett J E, Anthonisen N R, Woods R, Paré P D, Sandford A J
Abstract excerpt
BACKGROUND: Non-specific bronchial hyperresponsiveness (NSBH) is a known predictor of accelerated rate of decline in lung function in smokers. Polymorphisms of the beta(2) adrenergic receptor (ADRB2) have previously been associated with NSBH and bronchodilator response (BDR) in asthmatics. Based on these associations, we hypothesised that ADRB2 polymorphisms would be associated with NSBH and BDR as well as an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
